NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/06/2024
Back to search
Official data from USPTO
MEDIDELIC
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
48
Latest update
02/06/2024
Trademark type
Word
Nice classes
42
Filing date
02/03/2021
Registration date
02/06/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/06/2024
Last transaction
02/06/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
11/28/2022
First use in commerce
11/28/2022
Drawing code
4
Owner type
01
Owner location
Phoenix, AZ
Examiner
SULLIVAN,JOHN C
Law office
M50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Newman, David
Representatives
Dean H. Kayes LAW OFFICE OF DEAN H. KAYES, P.C.
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Biotechnology research; Research and development in the pharmaceuticalbioenergetic imprinting and biotechnology fields; Providing information on the subject of scientific research in the field of biochemistrybiological signaling and biotechnology; Development of new technology for others in the field of biotechnology; Scientific Research and Development of AbsorptionDistributionMetabolismExcretion and Toxicity (ADMET) modelingphysiologically based pharmacokinetic (PBPK) and physiologically based biopharmaceutics (PBBM) modeling and simulation software for the pharmaceutical and biotechnology industries; Research and Development of software that allows pharmaceutical scientists to predict certain key potential endpoints and dynamicsin silicothereby reducing research and development costs and helping clients make better projects decisions sooner that includes PBBK (Physical based pharmacokinetics)PBBM (Physiologically based biopharmaceutics)NOAEL (No observed adverse effect level); Scientific Research and Development utilizing a proprietary algorithm and artificial intelligence that utilizes a combination of lifestylehospitalizationemergency room usemortality and outcomes data to assist the healthcare industry and workers in identifying groups at high risk and populations that can benefit from various therapeutic approaches; Scientific Research and Development of drugs and therapies through applying interactive maps that identify ideal target populations for various therapeutic approaches including the mapping of surfaces that apply socioeconomic and environmental factors such as access to or lack of access to transportation or nutritious foodexposure to high stress and artificial intelligence analysis considering the suitability of various drugs or therapies
Publications
History of USPTO decisions and trademark events.
48 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
02/06/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
01/03/2024
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
01/02/2024
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
12/22/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12/20/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/19/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
12/19/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/19/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
12/19/2023
SNEA
SU-EXAMINER'S AMENDMENT WRITTEN
12/19/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
09/04/2023
GNFR
FINAL REFUSAL E-MAILED
09/04/2023
CNFR
SU - FINAL REFUSAL - WRITTEN
09/04/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/31/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/31/2023
ALIE
ASSIGNED TO LIE
08/31/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/19/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/20/2023
GNRT
NON-FINAL ACTION E-MAILED
01/20/2023
CNRT
SU - NON-FINAL ACTION - WRITTEN
01/20/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/20/2023
IUAF
USE AMENDMENT FILED
01/10/2023
EISU
TEAS STATEMENT OF USE RECEIVED
01/10/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/01/2022
EX1G
SOU EXTENSION 1 GRANTED
11/30/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/29/2022
NREV
NOTICE OF REVIVAL - E-MAILED
10/24/2022
TPEX
SOU EXTENSION RECEIVED WITH TEAS PETITION
10/22/2022
PETG
PETITION TO REVIVE-GRANTED
10/22/2022
PROA
TEAS PETITION TO REVIVE RECEIVED
10/22/2022
MAB6
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
09/06/2022
ABN6
ABANDONMENT - NO USE STATEMENT FILED
09/05/2022
EXT1
SOU EXTENSION 1 FILED
08/01/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
02/01/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/07/2021
PUBO
PUBLISHED FOR OPPOSITION
12/07/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/17/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/02/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/02/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/02/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/02/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/24/2021
GNRT
NON-FINAL ACTION E-MAILED
08/24/2021
CNRT
NON-FINAL ACTION WRITTEN
08/24/2021
DOCK
ASSIGNED TO EXAMINER
08/20/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/06/2021
NWAP
NEW APPLICATION ENTERED
02/06/2021
Continuous trademark protection
Get notified about every new filing that threatens MEDIDELIC or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.